« Back
Home /
OLIG2 Antibody

OLIG2 Antibody

Item no.	E10-30167
Manufacturer	Enogene
Amount	100 ug/100 ul
Quantity options	100 ug/100 ul 50 ug/50 ul 100 ug/100 ul 100 ul
Category	Antibodies Immunohistochemistry Western Blot ELISA Immunofluorescence Primary Antibodies
Type	Antibody
Format	Liquid
Applications	WB, IF, IHC, ELISA
Specific against	Human (Homo sapiens)
Host	Mouse
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	BHLHB1, OLIGO2, RACK17, PRKCBP2, bHLHe19, OLIG2
Similar products	OLIG2
Available
Manufacturer - Applications	WB, IHC, IF, ELISA. Not yet tested in other applications.
Manufacturer - Conjugate / Tag	This antibody is also available with the following conjugates: AF350, AF405L, AF405M, AF405S, AF488, AF514, AF532, AF546, AF555, AF568, AF594, AF610, AF635, AF647, AF680, AF700, AF750, AF790, APC, AP, Biotin, Cy3, Cy5.5, Cy5, Cy7, FITC, HRP, PE, Magnetic beads (1 um, 2.8 um, 3 um, 4.5 um, 5 um, 10 um, 15 um, 20 um, 30 um, or different size option) Please contact sales@hoelzel.de for pricing and availability.
Storage Conditions	Store at 4C, for long term storage, store at -20C.
Molecular Weight	32kDa
Immunogen	Purified recombinant fragment of human OLIG2 expressed in E. Coli.
Research Area	Autophagy antibody, Cancer, Cardiovascular, Cell Biology, Epigenetics and Nuclear Signaling, Developmental Biologys, Immunology, Drug Discovery Products, Metabolism, Neuroscience, Signal Transduction, Stem Cells
Background	This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14; 21)(q11.2; q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable.
Recommended Dilutions	WB: 1/500 - 1/2000, IHC: 1/200-1/1000, IF: 1/200-1/1000, ELISA: Propose dilution 1/10000.
Formulation Description	Ascitic fluid containing 0.03% sodium azide.
CiteID	EN0013845

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

E10-30167-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug/100 ul

available

Delivery expected until 11/27/2025

Express Delivery: Save 31 days

Compare

Add to wishlist

Get an offer